Tagada for Peptide Companies: What It Is, What It Publishes, and What We Could Not Verify

What is Tagada, and is it relevant to peptide companies?

Tagada is an ecommerce checkout and CRM platform with its own payment processor, TagadaPay, operated by TagadaPay LLC of Houston, Texas. It is relevant to peptide companies because TagadaPay publicly lists peptides as a category it onboards, subject to a mandatory account-manager call, and publishes its reserve, payout and termination terms before you apply. Whether it suits a given peptide business depends on underwriting, pricing and contract terms that Tagada does not publish for this category.

This profile is part of our payments series. For the underwriting mechanics behind any high-risk processor — MCCs, reserves, chargeback thresholds — read how high-risk underwriting actually works first.

What does Tagada actually offer?

Product	What Tagada says it is	Relevance to peptide operators
Tagada CRM	“The Ecommerce OS”: checkout pages, funnel builder, one-click upsells, subscriptions and dunning, CRM, email and SMS, A/B testing, and orchestration across “50+ gateways” including Stripe, NMI, Adyen, Airwallex and its own TagadaPay	A checkout layer that can sit on Shopify or WooCommerce or run standalone; routes to whichever processors you hold
TagadaPay	Tagada’s own processor, claiming “100+ acquirers, one API,” one KYC package distributed across its processor network, and smart routing between MIDs	The part that decides whether a peptide business can take card payments
Tagada Rx	An opt-in telehealth add-on: medical intake, clinician review, e-prescribing, partner pharmacy fulfilment and rebilling on ship day	Relevant to prescription-based telehealth models only, not research-use suppliers

TagadaPay states that you can use the processor alone behind an existing storefront, or take both products together. The docs describe a Node SDK, a headless SDK, a REST API and plugin tooling.

What does Tagada publish about peptide merchants?

On TagadaPay’s “Who we onboard” section, “Peptides” appears in the ecommerce list alongside supplements, CBD and high-ticket goods, with this condition attached: “Requires a call with an account manager before your dashboard is unlocked — whatever your volume.”

The same page states “No industry ruled out up front,” and that “each file is still underwritten, with enhanced review on regulated verticals.” It asks applicants for a monthly volume band and says applying below the lowest band is allowed but means underwriting “will look at your file more closely.”

What the page does not say is what kind of peptide business qualifies. It does not distinguish research-use suppliers from consumer-facing stores, state required documents for the category, or describe which website claims would disqualify an applicant. Read “listed” as “eligible to apply,” not “will be approved.”

Tagada’s own January 2026 blog post on high-risk ecommerce names supplements, nutraceuticals, weight loss, subscriptions, telehealth and CBD as categories most processors flag as high risk. It does not discuss peptides specifically.

What are Tagada’s published fees and processor terms?

Term	What Tagada publishes	Source page
CRM fee	1.25% + $0.29 per successful transaction; reduced to 0.8% when processing $50K+/month on TagadaPay	tagada.io/pricing
Platform fee	$75/week, waived at scale (the page describes the threshold both as “above $50K/mo” and as variable fees exceeding $50,000/month — confirm which applies)	tagada.io/pricing
Processing rate	From 2.9% + $0.29; “high-risk verticals and edge cases are priced case by case”	tagadapay.io
Minimum volume	None stated	tagadapay.io
Rolling reserve	Usually 10% of each sale, held 60–90 days; can be lower or zero; can be raised to 40% if chargebacks or alerts spike; changes sent in writing with 30 days to request review	tagadapay.io
Payouts	Daily; T+2 in the US, Canada, UK, EU and Switzerland; longer in some markets and on some high-risk contracts	tagadapay.io
Dispute fees	$25 per dispute, $30 per chargeback alert, unless the agreement states otherwise; network fines passed through at cost	tagadapay.io
Suspension	Immediate stop possible for prohibited products, selling outside what was approved, unanswered information requests or acquirer/network demand; stated to be a human decision	tagadapay.io
Leaving	30 days’ notice either side; balance and reserve held up to 180 days after termination (longer while claims are open); card tokens and customers exportable	tagadapay.io

Two practical readings for a peptide operator. First, the 2.9% figure is a floor; Tagada’s own cost simulator states it “cannot tell you whether your industry pays the floor or more.” Second, the reserve and post-termination hold together define your worst-case cash exposure — model them before scaling ad spend on this processor or any other.

What could we not verify?

Question	Status	Note
Pricing for peptide merchants	Could not verify	Not published; Tagada’s simulator says case-by-case pricing ranges are “not published yet”
Acquiring banks behind TagadaPay	Could not verify	Not named on the pages reviewed; ask which acquirer and MCC your MID would sit under
“100+ acquirers” and authorisation-rate claims	Could not verify	Vendor claims; homepage counters render dynamically and could not be independently checked
PCI DSS Level 1, SOC 2, ISO 27001	Claimed, not verified	Listed on the site; we did not review attestation documents
Which peptide business models are accepted	Could not verify	No published criteria distinguishing research-use from consumer-facing stores
Server-side Google Ads conversions	Could not verify	Pricing page lists server-side tracking for Google; the docs we reviewed describe Google tags loaded client-side
Independent customer experience	Not assessed	We did not survey users or rely on review sites
Company size and founding	Third-party only	LinkedIn lists founding in 2024 and a Houston headquarters; not confirmed by Tagada’s own pages beyond the Houston address in its terms

What should a peptide operator check before signing?

1. Which acquirer and MCC. Ask directly. It determines network rules and what happens if the acquirer later exits the category.
2. Your written reserve and payout schedule. The published 10% / 60–90 days is “usually,” not a promise; get your figure in the pricing agreement, as Tagada says it will be.
3. Approved scope. Suspension terms include “selling outside what you were approved for.” Make sure the approved description covers every product line you plan to sell, including anything you may add later.
4. The Terms of Use non-compete. Section 13 of Tagada’s Terms of Use (last updated 4 August 2025) says that during use and for 12 to 24 months afterwards you agree not to build or offer a competing checkout or funnel technology. Most merchants will never be affected; agencies and platforms should read it carefully.
5. Governing law. The Terms specify US law with exclusive jurisdiction in Texas courts.
6. Exit mechanics. Token portability is a stated feature; confirm in writing how it works with your next processor before you depend on it.

How does Tagada work with Google Ads tracking?

Tagada’s pixel documentation describes a single Google slot that accepts a Google Tag Manager container (GTM-), a GA4 measurement ID (G-) or a Google Ads ID (AW-). With a GA4 or Ads ID, Tagada loads gtag.js and fires standard ecommerce events such as begin_checkout and purchase; with GTM it pushes events to the dataLayer and you configure conversion tags inside the container. Purchase events are described as deduplicated.

Its tracking overview documents server-side postbacks for several third-party ad trackers and a server-side integration with Hyros, and states that operators running only Meta and Google Ads can rely on those platforms’ native pixels. We did not find documentation for server-side Google Ads conversion uploads or enhanced conversions in the pages we reviewed.

If you move checkout onto any third-party platform, verify end to end that purchases reach Google Ads with the right value and currency before switching budgets — see conversion tracking for peptide ecommerce.

Does Tagada Rx matter, and who might Tagada fit?

Tagada Rx is for prescription-based telehealth. Its documentation describes two modes: Merchant of Record, where Tagada is the seller of record and carries LegitScript and compliance, priced at 6.9% of GMV with processing included; and Direct Merchant, described as “coming soon” at 4.9% of GMV plus a $4,980 setup, where you hold your own LegitScript certification and MIDs. DEA-controlled products are not allowed in Merchant of Record mode. For a research-use supplier none of this applies.

Based only on what is published, Tagada is worth evaluating if you want checkout, subscriptions and multi-processor routing in one layer and are prepared to go through enhanced underwriting. It is a weaker fit if you need published category pricing before engaging, or if a non-compete on checkout technology is unacceptable for your business. Those are conditions to test, not conclusions.

For help deciding whether your site is ready for payment underwriting and Google review at the same time, try the Google Ads Readiness Score or book a strategy call.

Sources

• Tagada — homepage and pricing
• TagadaPay — processor page (industries, reserves, payouts, suspension, termination)
• Tagada — Terms of Use (last updated 4 August 2025)
• Tagada docs — Pixels, Tracking & Attribution, Tagada Rx overview and Rx operating modes
• Tagada blog — High-Risk Ecommerce (15 January 2026)
• LinkedIn — Tagada company page (third-party, company-reported)

All pages read 23 September 2026. Vendor terms change without notice; the signed agreement governs.

Frequently asked